| Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus … KJ Schmitz, J Wohlschlaeger, H Lang, GC Sotiropoulos, M Malago, ... Journal of hepatology 48 (1), 83-90, 2008 | 373 | 2008 |
| Clinical, prognostic, and therapeutic aspects of urachal carcinoma—a comprehensive review with meta-analysis of 1,010 cases T Szarvas, O Módos, C Niedworok, H Reis, A Szendröi, MA Szász, ... Urologic Oncology: Seminars and Original Investigations 34 (9), 388-398, 2016 | 176 | 2016 |
| Prognostic value of tissue and circulating levels of IMP3 in prostate cancer T Szarvas, S Tschirdewahn, C Niedworok, G Kramer, S Sevcenco, H Reis, ... International journal of cancer 135 (7), 1596-1604, 2014 | 176 | 2014 |
| Thoracic staging in lung cancer: prospective comparison of 18F-FDG PET/MR imaging and 18F-FDG PET/CT P Heusch, C Buchbender, J Köhler, F Nensa, T Gauler, B Gomez, H Reis, ... Journal of Nuclear Medicine 55 (3), 373-378, 2014 | 124 | 2014 |
| Tumor markers as a diagnostic key for hilar cholangiocarcinoma B Juntermanns, S Radunz, M Heuer, S Hertel, H Reis, JP Neuhaus, ... European Journal of Medical Research 15, 357-361, 2010 | 108 | 2010 |
| Toll-like receptor 4 variant D299G induces features of neoplastic progression in Caco-2 intestinal cells and is associated with advanced human colon cancer A Eyking, B Ey, M Rünzi, AI Roig, H Reis, KW Schmid, G Gerken, ... Gastroenterology 141 (6), 2154-2165, 2011 | 104 | 2011 |
| AKT and ERK1/2 signaling in intrahepatic cholangiocarcinoma KJ Schmitz, H Lang, J Wohlschlaeger, GC Sotiropoulos, H Reis, ... World journal of gastroenterology: WJG 13 (48), 6470, 2007 | 96 | 2007 |
| SF3B1 and BAP1 mutations in blue nevus-like melanoma KG Griewank, H Müller, LA Jackett, M Emberger, I Möller, ... Modern Pathology 30 (7), 928-939, 2017 | 95 | 2017 |
| NF1 mutations in conjunctival melanoma SL Scholz, I Cosgarea, D Süßkind, R Murali, I Möller, H Reis, ... British Journal of Cancer 118 (9), 1243-1247, 2018 | 79 | 2018 |
| MiR-205 and MiR-373 are associated with aggressive human mucinous colorectal cancer A Eyking, H Reis, M Frank, G Gerken, KW Schmid, E Cario PloS one 11 (6), e0156871, 2016 | 78 | 2016 |
| PD-L1 expression in urothelial carcinoma with predominant or pure variant histology: concordance among 3 commonly used and commercially available antibodies H Reis, R Serrette, J Posada, V Lu, Y Chen, A Gopalan, SW Fine, ... The American journal of surgical pathology 43 (7), 920-927, 2019 | 77 | 2019 |
| Identification of novel biomarker candidates for the immunohistochemical diagnosis of cholangiocellular carcinoma J Padden, DA Megger, T Bracht, H Reis, M Ahrens, M Kohl, M Eisenacher, ... Molecular & Cellular Proteomics 13 (10), 2661-2672, 2014 | 76 | 2014 |
| Diagnostic accuracy of whole-body PET/MRI and whole-body PET/CT for TNM staging in oncology P Heusch, F Nensa, B Schaarschmidt, R Sivanesapillai, K Beiderwellen, ... European journal of nuclear medicine and molecular imaging 42, 42-48, 2015 | 75 | 2015 |
| MET expression in advanced non–small-cell lung cancer: effect on clinical outcomes of chemotherapy, targeted therapy, and immunotherapy H Reis, M Metzenmacher, M Goetz, N Savvidou, K Darwiche, C Aigner, ... Clinical lung cancer 19 (4), e441-e463, 2018 | 72 | 2018 |
| High prevalence of concomitant oncogene mutations in prospectively identified patients with ROS1-positive metastatic lung cancer M Wiesweg, WEE Eberhardt, H Reis, S Ting, N Savvidou, C Skiba, ... Journal of Thoracic Oncology 12 (1), 54-64, 2017 | 69 | 2017 |
| Cytomegalovirus reactivation in patients with refractory checkpoint inhibitor-induced colitis C Franklin, I Rooms, M Fiedler, H Reis, L Milsch, S Herz, E Livingstone, ... European Journal of Cancer 86, 248-256, 2017 | 66 | 2017 |
| Enhanced stromal syndecan-1 expression is an independent risk factor for poor survival in bladder cancer T Szarvas, H Reis, G Kramer, SF Shariat, F Vom Dorp, S Tschirdewahn, ... Human pathology 45 (4), 674-682, 2014 | 65 | 2014 |
| Impact of RAS mutation subtype on clinical outcome—a cross-entity comparison of patients with advanced non-small cell lung cancer and colorectal cancer M Wiesweg, S Kasper, K Worm, T Herold, H Reis, L Sara, ... Oncogene 38 (16), 2953-2966, 2019 | 63 | 2019 |
| Detection of significant prostate cancer using target saturation in transperineal magnetic resonance imaging/transrectal ultrasonography–fusion biopsy S Tschirdewahn, M Wiesenfarth, D Bonekamp, L Püllen, H Reis, A Panic, ... European Urology Focus 7 (6), 1300-1307, 2021 | 62 | 2021 |
| Inhibitory role of the small leucine-rich proteoglycan biglycan in bladder cancer C Niedworok, K Röck, I Kretschmer, T Freudenberger, N Nagy, T Szarvas, ... PloS one 8 (11), e80084, 2013 | 61 | 2013 |
kurt werner schmidProfessor der Medizin, Pathologe, Universität Duisburg-EssenVerified email at uk-essen.de
